Ozempic

‘Why should the taxpayer be made to pay for other people’s bad food choices?’ Why this TOP DOC believes that ‘skinny jabs’ such as Ozempic should NOT be on the HSE’s Drug Payment Scheme

by

The Ozempic Debate: Cost, Side Effects and the Future of Obesity Treatment Growing concerns surrounding weight loss drugs like Ozempic are fueling a debate about the best approach to tackling obesity. Professor Ray O’Connor of the University of Limerick School of Medicine has voiced concerns about the financial implications and potential side effects of widespread … Read more

GLP‑1 drugs may do more than control blood sugar and weight

by

Beyond Weight Loss: The Expanding Promise of GLP-1 Medications Drugs like Ozempic and Wegovy, initially designed to manage type 2 diabetes, are now revealing a broader spectrum of potential health benefits. While widely recognized for their impact on weight loss and blood sugar control, emerging research suggests these GLP-1 receptor agonists could address a range … Read more

FDA approves ‘Wegovy HD’ with triple the maximum dose of weight loss drug

by

The Evolution of Weight Loss Drugs: Beyond Ozempic and Mounjaro If you haven’t heard of Ozempic or Mounjaro, you’ve likely been living under a rock. These GLP-1 medications have exploded in popularity, transitioning from niche diabetes treatments to mainstream weight loss solutions. But the story doesn’t end there. The pharmaceutical landscape is rapidly evolving, with … Read more

Potent Ozempic Alternative Hiding in Python Blood Causes Weight Loss Without the Nauseating Side Effects

by

The Python’s Secret to Weight Loss: A New Hope Beyond Ozempic? Millions are turning to drugs like Ozempic for weight loss, with adult obesity rates declining for the first time in a decade. However, the unpleasant side effects – nausea, muscle loss, and digestive issues – often lead nearly half of patients to discontinue use … Read more

When I hit perimenopause and piled on weight I was desperate to lose it. I did, with this quick fix method. But it came at the cost of my glorious thick hair. Don’t make the same irreversible mistake I did…

by

The Ozempic Hair Loss Paradox: A Growing Concern for Women A seemingly innocuous comment from a 13-year-old daughter sparked a personal crisis for Olivia Falcon: noticeable hair thinning. This wasn’t simply a cosmetic concern; it was a direct consequence of using Ozempic, a weight-loss injection, following the hormonal shifts of perimenopause. Falcon’s experience, detailed in … Read more

Ozempic Goes Generic —But Not in the US

by

Ozempic’s Patent Cliff: A Global Shift in Diabetes and Weight Loss Treatment A pivotal moment is unfolding in the pharmaceutical landscape as patent protections for semaglutide – the active ingredient in both Ozempic (for diabetes) and Wegovy (for weight loss) – expire in key global markets. This expiration, beginning Saturday, March 28, 2026, is poised … Read more

Ozempic is getting generics as low as $15 — what it means for Americans

by

India’s Ozempic Revolution: Will Cheaper Weight Loss Drugs Reach US Shores? The global weight-loss landscape is on the cusp of a dramatic shift. This weekend marks a pivotal moment as Indian pharmaceutical companies gain the green light to manufacture and sell generic versions of Ozempic and Wegovy, the blockbuster drugs transforming diabetes and obesity treatment. … Read more

Wegovy and Ozempic users reveal frightening ‘dark side’ of popular weight loss drugs

by

The Dark Side of Weight Loss Drugs: Blindness and Beyond GLP-1 receptor drugs like Ozempic and Wegovy have become cultural phenomena, lauded by celebrities and increasingly prescribed for both type 2 diabetes and weight management. However, a growing number of reports are surfacing detailing frightening side effects, prompting lawsuits and raising serious questions about the … Read more

FDA sends letter to Novo Nordisk over potential GLP-1 side effects

by

FDA Scrutinizes Novo Nordisk: Reporting Lapses and Rising Safety Concerns with Ozempic & Wegovy The FDA recently issued a warning letter to Novo Nordisk, the manufacturer of Ozempic and Wegovy, citing failures to adequately report potential adverse effects and deaths linked to the popular GLP-1 medications. This action underscores growing scrutiny surrounding these drugs as … Read more

Experts discover a new threat from weight loss drugs

by

Weight-Loss Drugs and Vision Loss: What the Latest Research Reveals Recent studies are raising concerns about a potential link between semaglutide-based weight-loss medications, like Wegovy and Ozempic, and an increased risk of ischemic optic neuropathy (ION), a condition that can lead to vision loss. While the research is preliminary, it’s prompting closer scrutiny of these … Read more

© 2026 Newsy Today. All rights reserved.


For contact, advertising, copyright, issues email: office@newsy-today.com

For contact, advertising, copyright, issues email: office@newsy-today.com